On Demand
28 min
Share webinar
![](https://framerusercontent.com/images/4nyjOLiwPGg3520zNUjC0yDlBFs.webp)
Discover how Comprehensive Molecular Tumor Analysis (CMTA) revolutionizes cancer treatment by integrating RNA-seq and Tumor Microenvironment (TME) data. Learn how this cutting-edge approach with MGI DNBSEQ technology offers precise, targeted therapies, enhancing personalized care and outcomes for cancer patients. Don't miss the chance to elevate your understanding and impact in oncology.
![Dr. Marie-laure Yaspo Co-founder & Chief Scientific Officer @Alacris Theranostics GmbH](https://framerusercontent.com/images/xblq5hTMdXHCKtyMvSdfcHwtzw.png)
Dr. Marie-laure Yaspo